A methylxanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Mechanistically, theophylline acts as a phosphodiesterase inhibitor, adenosine receptor blocker, and histone deacetylase activator. Theophylline is marketed under several brand names such as Uniphyl and Theochron, and it is indicated mainly for asthma, bronchospasm, and COPD.
Synonyms
Theophylline anhydrous
Theophylline sodium glycinate
Teofilina
Theophyllin
Theophylline, anhydrous
1,3-dimethyl-7H-purine-2,6-dione
1,3-dimethylxanthine
Theophylline
Brand Names
Apo-theo ER
PMS-theophylline Elixir
Theolair
Theophylline 4mg and 5% Dextrose Inj
Theo-24
Theophylline 1.6mg and 5% Dextrose Inj
Theo ER
Theophylline Elx
Theophylline 0.8mg and 5% Dextrose Inj
Slo-bid 50
Slo-bid 200
Theophylline Anhydrous
Aa-theo LA
Teva-theophylline SR
Quibron T/SR
Theolair SR Tab 500mg
Theolair Tab 250mg
Senophylline
Theochron Srt 100mg
Theochron Srt 200mg
Uniphyl
Elixophyllin
Idm Tab
Theophylline (Anhydrous)
Theophylline 80mg/15ml
Theophylline Elixir
Theophylline
Elixir De Theophylline
Pulmophylline Elx
Theo-dur 300 mg
Theophylline Rougier Elixir
Slo-bid 100
I D M Expectorant Tab
Tedral Tab
Quibron T SR Tab 300mg
Theochron Srt 300mg
Slo-bid 300
Theophylline(Anhydrous)
Theo-dur 450 mg
Theo-SR 300 Srt 300mg
Theolair SR Tab 200mg
Theophylline in Dextrose
Theo-dur 100 mg
Quibron-T
Ratio-theo-bronc
Theo-dur 200 mg
Theolair Tab 125mg
Theolair SR Tab 250mg
Theophylline 0.8mg/ml In 5% Dextrose Inj
Theolair SR Tab 300mg
Theophylline Extended Release
Indication
For the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.
Categories
Agents that reduce seizure threshold
Alkaloids
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Cytochrome P-450 CYP1A2 Substrates
Cytochrome P-450 CYP1A2 Substrates with a Narrow Therapeutic Index
Cytochrome P-450 CYP2C8 Substrates
Cytochrome P-450 CYP2D6 Substrates
Cytochrome P-450 CYP2D6 Substrates with a Narrow Therapeutic Index
Cytochrome P-450 CYP2E1 Substrates
Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index
Cytochrome P-450 CYP3A Substrates
Cytochrome P-450 CYP3A4 Substrates
Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682